NAD(P)H:quinone oxidoreductase 1 protects bladder epithelium against painful bladder syndrome in mice

Free Radical Biology and Medicine

Volumn 53, Issue 10, 2012, Pages 1886-1893

  Patrick, Brad A ^a   Das, Amitava ^a,b   Jaiswal, Anil K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Bladder; Free radicals; Interstitial cystitis; NQO1; Painful bladder syndrome

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADHESION; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER EPITHELIUM; DISEASE COURSE; DOWN REGULATION; ENERGY METABOLISM; FEMALE; HUMAN; HUMAN CELL; INTERSTITIAL CYSTITIS; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL ADHESION; CELLS, CULTURED; CYSTITIS, INTERSTITIAL; ENERGY METABOLISM; FEMALE; GENE DOSAGE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; NAD(P)H DEHYDROGENASE (QUINONE); REACTIVE OXYGEN SPECIES; URINARY BLADDER; UROTHELIUM;

ANIMALIA; MUS;

EID: 84867344347     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.08.584     Document Type: Article

References (32)

1. D. Ross, J.K. Kepa, S.L. Winski, H.D. Beall, A. Anwar, and D. Siegel NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphism Chem. Biol. Interact. 129 2001 77 97
2. S. Park, H. Zhao, M.R. Spitz, H.B. Grossman, and X. Wu An association between NQO1 genetic polymorphism and risk of bladder cancer Mutat. Res. 536 2003 131 137
3. J. Kaspar, S.K. Niture, and A.K. Jaiswal Nrf2:INrf2 (Keap1) signaling in oxidative stress Free Radic. Biol. Med. 47 2009 1304 1309
4. S. Sanyal, C. Ryk, P.J. De Verdier, G. Steineck, P. Larsson, E. Onelov, K. Hemminki, and R. Kumar Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms Scand. J. Urol. Nephrol. 41 2007 182 190
5. M. Rosenberg, D.K. Newman, and S.A. Page Interstitial cystitis/painful bladder syndrome: symptom recognition is key to identification, treatment Cleveland Clin. J. Med. 74 Suppl. 3 2007 S54 S62
6. E. Kelada, and A. Jones Interstitial cystitis Arch. Gynecol. Obstet. 275 2007 223 229
7. R.E. Hurst, R.M. Moldwin, and S.G. Mulholland Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis Urology 69 4 Suppl. 2007 S17 S23
8. S. Keay Cell signaling in interstitial cystitis/painful bladder syndrome Cell. Signalling 20 2008 2174 2179
9. G.R. Sant, D. Kempuraj, J.E. Marchand, and T.C. Theoharides The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis Urology 69 4 Suppl. 2007 34 40
10. A.R. Stone, K.B. Quattrocchi, C.H. Miller, and J.P. MacDermott Role of the immune system in interstitial cystitis Semin. Urol 9 1991 108 114
11. T. Ratliff, C.G. Klutke, M. Hofmeister, F. He, J.H. Russell, and M.J. Becich Role of the immune response in interstitial cystitis Clin. Immunol. Immunopathol. 74 1995 209 216
12. V. Radjendirane, P. Joseph, Y.H. Lee, S. Kimura, A.J. Klein-Szanto, F.J. Gonzalez, and A.K. Jaiswal Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity J. Biol. Chem. 273 1998 7382 7389
13. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc. Natl. Acad. Sci. USA 76 1979 4350 4354
14. G. Pejler, M. Abrink, M. Ringvall, M. Ringvall, and S. Wernersson Mast cell proteases Adv. Immunol. 95 2007 167 225
15. M.T. Robbins, J. DeBerry, and T.J. Ness Chronic physiological stress enhances nociceptive processing in the urinary bladder in high-anxiety rats Physiol. Behav. 91 2007 544 550
16. L.A. Kilpatrick, E. Ornitz, H. Ibrahimovic, C.S. Hubbard, L.V. Rodriguez, E.A. Mayer, and B.D. Naliboff Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome J. Urol. 184 2010 958 963
17. C.R. Benton, D.C. Wright, and A. Bonen PGC1-alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions Appl. Physiol. Nutr. Metab. 33 2008 843 862
18. Y. Zhou, L. Jiang, and L. Rui Identification of MUP1 as a regulator for glucose and lipid metabolism in mice J. Biol. Chem. 284 2009 11152 11159
19. X. Hui, W. Zhu, Y. Wang, K.S. Lam, J. Zhang, D. Wu, E.W. Kraegen, Y. Li, and A. Xu Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice J. Biol. Chem. 284 2009 14050 14057
20. X. Gong, L. Kole, K. Iskander, and A.K. Jaiswal NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53 Cancer Res 67 2007 5380 5388
21. B.A. Patrick, X. Gong, and A.K. Jaiswal Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer Oncogene 30 2011 1098 1107
22. P.J. Fernandez-Marcos, and J. Auwerx Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis Am. J. Clin. Nutr. 93 2011 8845 8890
23. R. Kim, W. Liu, X. Chen, K.J. Kreder, and Y. Luo Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models J. Biomed. Biotech 2011 2011 937061 937069
24. Oottamasathien, S.; Wanjian, J.; Lindsi, M.; Slack, S.; Zhang, J.; Skardal, A.; Job, K.; Kennedy, T.P.; Dull, R.O.; Prestwich, G.D. A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides. J. Urol. 186(4 Suppl.):1684-16892; 2011.
25. S. Keay, S. Leitzell, A. Ochrzcin, G. Clements, M. Zhan, and D. Johnson A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study BMC Urol. 12 2012 17
26. K. Iskander, J. Li, S. Han, P. Eickelmann, C. Neuhaus, B.J. Schmitz-Drager, and H. Sies NQO1 and NQO2 regulation of humoral immunity and autoimmunity J. Biol. Chem. 281 2006 30917 30924
27. A.K. Jaiswal, D.W. Bell, V. Radjendirane, and J.R. Testa Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphism Pharmacogenetics 9 1999 413 418
28. R.D. Traver, T. Horikoshi, K.D. Danenberg, T.H. Stadbauer, P.V. Danenberg, D. Ross, and N.W. Gibson NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity Cancer Res. 52 1992 797 802
29. D. Siegel, A. Anwar, S.L. Winski, J.K. Kepa, K.L. Zolman, and D. Ross Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1 Mol. Pharmacol. 59 2001 263
30. D. Siegel, S.M. McGuinness, S.L. Winski, and D. Ross Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1 Pharmacogenetics 9 1999 113 121
31. K.T. Kelsey, D. Ross, R.D. Traver, D.C. Christiani, Z.F. Zuo, M.R. Spitz, M. Wang, X. Xu, B.K. Lee, B.S. Schwartz, and J.K. Wiencke Ethnic variation in the prevalence of a common NAD(P)H:quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy Br. J. Cancer 76 1997 852 854
32. W.A. Schulz, A. Krummeck, I. Rosinger, P. Eickelmann, C. Neuhaus, T. Ebert, B.J. Schmitz-Drager, and H. Sies Predisposition towards urolithiasis associated with the NQO1 null-allele Pharmacogenetics 8 1998 453 454